Open-label pilot study of ziprasidone for refractory generalized anxiety disorder.
Publication
, Journal Article
Snyderman, SH; Rynn, MA; Rickels, K
Published in: J Clin Psychopharmacol
October 2005
Duke Scholars
Published In
J Clin Psychopharmacol
DOI
ISSN
0271-0749
Publication Date
October 2005
Volume
25
Issue
5
Start / End Page
497 / 499
Location
United States
Related Subject Headings
- Thiazoles
- Psychiatry
- Psychiatric Status Rating Scales
- Piperazines
- Pilot Projects
- Middle Aged
- Male
- Humans
- Female
- Drug Resistance
Citation
APA
Chicago
ICMJE
MLA
NLM
Snyderman, S. H., Rynn, M. A., & Rickels, K. (2005). Open-label pilot study of ziprasidone for refractory generalized anxiety disorder. J Clin Psychopharmacol, 25(5), 497–499. https://doi.org/10.1097/01.jcp.0000177853.15910.de
Snyderman, Steven H., Moira A. Rynn, and Karl Rickels. “Open-label pilot study of ziprasidone for refractory generalized anxiety disorder.” J Clin Psychopharmacol 25, no. 5 (October 2005): 497–99. https://doi.org/10.1097/01.jcp.0000177853.15910.de.
Snyderman SH, Rynn MA, Rickels K. Open-label pilot study of ziprasidone for refractory generalized anxiety disorder. J Clin Psychopharmacol. 2005 Oct;25(5):497–9.
Snyderman, Steven H., et al. “Open-label pilot study of ziprasidone for refractory generalized anxiety disorder.” J Clin Psychopharmacol, vol. 25, no. 5, Oct. 2005, pp. 497–99. Pubmed, doi:10.1097/01.jcp.0000177853.15910.de.
Snyderman SH, Rynn MA, Rickels K. Open-label pilot study of ziprasidone for refractory generalized anxiety disorder. J Clin Psychopharmacol. 2005 Oct;25(5):497–499.
Published In
J Clin Psychopharmacol
DOI
ISSN
0271-0749
Publication Date
October 2005
Volume
25
Issue
5
Start / End Page
497 / 499
Location
United States
Related Subject Headings
- Thiazoles
- Psychiatry
- Psychiatric Status Rating Scales
- Piperazines
- Pilot Projects
- Middle Aged
- Male
- Humans
- Female
- Drug Resistance